ClinicalMetric / Countries / Italy / coronary artery disease
← 🇮🇹 Italy Trials
🇮🇹 Italy Country × Condition

coronary artery disease Clinical Trials in Italy

Active clinical trials for coronary artery disease with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇮🇹 Italy

Active Trials in Italy (3)

NCT07291609
Recruiting

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

Enrollment
120 pts
Country
🇮🇹 Italy
Azienda Ospedaliera "Sant'Andrea"
View Trial →
NCT06074549
Recruiting

DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System

Enrollment
5,000 pts
Country
🇮🇹 Italy
Elixir Medical Corporation
View Trial →
NCT05248165
Recruiting

Naples PCI Registry

Enrollment
5,000 pts
Country
🇮🇹 Italy
Federico II University
View Trial →

Frequently Asked Questions

How many coronary artery disease clinical trials are active in Italy?
There are currently 3 active clinical trials for coronary artery disease with sites in Italy, of which 3 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in Italy?
To join a coronary artery disease clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in Italy?
Active coronary artery disease trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Italy Trials → Global coronary artery disease Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology